Relationship between the Level of Circulating CD45+ Platelets and Development of Restenosis after Implantation of Drug-Eluting Stents to Patients with Coronary Heart Disease


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The study was carried out in 126 patients with stable angina pectoris, who underwent elective coronary artery stenting with drug-eluting stents and follow-up angiography within 6-12 months thereafter. Five significant risk factors of restenosis were identified by binary comparisons of different variables. The logistic regression equation that included the level of CD45-positive platelets, diabetes, small vessel stenting, number of simultaneously implanted stents in one patient, and lesion length demonstrates the highest level of prediction of in-stent restenosis (OR=22.8; p<0.001). ROC-analysis demonstrated high prognostic value of the logit model (area under ROC curve 0.87, p<0.001). The data suggest that a close relationship exists between the development of restenosis and the level of circulating CD45+ platelets.

Авторлар туралы

Z. Gabbasov

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Хат алмасуға жауапты Автор.
Email: zufargabbasov@yandex.ru
Ресей, Moscow

S. Kozlov

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Ресей, Moscow

S. Byazrova

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Ресей, Moscow

I. Mel’nikov

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Ресей, Moscow

O. Saburova

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: zufargabbasov@yandex.ru
Ресей, Moscow


© Springer Science+Business Media New York, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>